Cost Analysis of 2 Empiric Antibacterial Regimens Containing Glycopeptides for the Treatment of Febrile Neutropenia in Patients with Acute Leukaemia

This publication has 33 references indexed in Scilit:

• Teicoplanin
  PharmacoEconomics, 1995
• Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity
  Antimicrobial Agents and Chemotherapy, 1991
• Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.
  1991
• The role of Gram-positive therapy in the neutropenic patient
  Journal of Antimicrobial Chemotherapy, 1991
• Comparison of vancomycin- and teicoplanin-induced histamine release and "red man syndrome"
  Antimicrobial Agents and Chemotherapy, 1990
• Ceftazidime Combined with a Short or Long Course of Amikacin for Empirical Therapy of Gram-Negative Bacteremia in Cancer Patients with Granulocytopenia
  New England Journal of Medicine, 1987
• Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients
  Antimicrobial Agents and Chemotherapy, 1987
• Infection in cancer patients: A continuing association
  The American Journal of Medicine, 1986
• Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.
  1978
• Origin of Infection in Acute Nonlymphocytic Leukemia
  Annals of Internal Medicine, 1972